{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:23:50Z","timestamp":1759937030085,"version":"3.40.5"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.045","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T20:49:56Z","timestamp":1547498996000},"page":"e24-e26","source":"Crossref","is-referenced-by-count":3,"title":["Catastrophic Secondary Infarctions with Onset Seizure Following Tissue Plasminogen Activator Therapy"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9455-3903","authenticated-orcid":false,"given":"Kosuke","family":"Matsuzono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younhee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Mashiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0628-7164","authenticated-orcid":false,"given":"Haruo","family":"Shimazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiji","family":"Koide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.12.045_bib0001","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1212\/WNL.54.3.679","article-title":"Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness","volume":"54","author":"Buchan","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.12.045_bib0002","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.STR.28.11.2109","article-title":"Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group","volume":"28","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.12.045_bib0003","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.04.001","article-title":"Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society","volume":"22","author":"Minematsu","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.12.045_bib0004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000103117","article-title":"The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis","volume":"24","author":"Sobesky","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.12.045_bib0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.8496","article-title":"Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS Randomized Clinical Trial","volume":"320","author":"Khatri","year":"2018","journal-title":"JAMA"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718307481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718307481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:34:06Z","timestamp":1553639646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718307481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1052305718307481"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.12.045","relation":{},"ISSN":["1052-3057"],"issn-type":[{"type":"print","value":"1052-3057"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}